Free Trial

Dyne Therapeutics (DYN) Insider Trading & Ownership

$34.73
-0.67 (-1.89%)
(As of 10/17/2024 ET)

Dyne Therapeutics (NASDAQ:DYN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
20.77%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$31.06 M
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$61.36 M
Get DYN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Dyne Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DYN Insider Buying and Selling by Quarter

Dyne Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/25/2024Dirk KerstenDirectorSell2,357$35.06$82,636.42  
9/23/2024Dirk KerstenDirectorSell40,831$35.32$1,442,150.92  
9/20/2024Dirk KerstenDirectorSell79,411$36.45$2,894,530.95  
9/18/2024Oxana BeskrovnayaInsiderSell2,339$34.55$80,812.45  
9/18/2024Richard William ScalzoSVPSell1,390$34.55$48,024.50  
9/18/2024Susanna Gatti HighCOOSell8,976$34.41$308,864.16  
9/4/2024John CoxCEOBuy32,000$33.04$1,057,280.00  
6/24/2024Susanna Gatti HighCOOSell10,163$35.33$359,058.79  
6/21/2024Susanna Gatti HighCOOSell29,787$35.01$1,042,842.87  
6/12/2024Susanna Gatti HighCOOSell40,000$33.36$1,334,400.00  
6/11/2024Oxana BeskrovnayaInsiderSell2,136$31.34$66,942.24  
6/10/2024Richard William ScalzoSVPSell1,590$30.23$48,065.70  
6/10/2024Susanna Gatti HighCOOSell80,000$30.24$2,419,200.00  
5/20/2024Oxana BeskrovnayaInsiderSell30,426$32.96$1,002,840.96  
5/16/2024Oxana BeskrovnayaInsiderSell2,705$28.27$76,470.35  
5/16/2024Richard William ScalzoSVPSell2,588$28.27$73,162.76  
5/16/2024Susanna Gatti HighCOOSell2,738$28.27$77,403.26  
3/11/2024Joshua T BrummCEOSell66,387$25.67$1,704,154.29  
3/11/2024Richard William ScalzoSVPSell2,672$25.28$67,548.16  
3/11/2024Susanna Gatti HighCOOSell2,292$25.70$58,904.40  
3/11/2024Wildon FarwellInsiderSell1,585$25.70$40,734.50  
3/7/2024Joshua T BrummCEOSell9,086$25.85$234,873.10  
3/7/2024Oxana BeskrovnayaInsiderSell2,373$25.85$61,342.05  
3/7/2024Richard William ScalzoSVPSell2,273$25.85$58,757.05  
3/7/2024Susanna Gatti HighCOOSell1,591$25.85$41,127.35  
2/29/2024Jonathan McneillInsiderSell4,268$27.50$117,370.00  
2/29/2024Joshua T BrummCEOSell5,520$27.50$151,800.00  
2/29/2024Richard William ScalzoSVPSell3,429$27.50$94,297.50  
2/28/2024Jason P RhodesDirectorSell190,920$24.84$4,742,452.80  
2/28/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell154,674$24.84$3,842,102.16  
2/26/2024Jason P RhodesDirectorSell248,219$23.72$5,887,754.68  
2/26/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell201,095$23.72$4,769,973.40  
2/23/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell159,542$22.70$3,621,603.40  
2/22/2024Jason P RhodesDirectorSell119,360$22.66$2,704,697.60  
2/21/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell184,501$22.57$4,164,187.57  
2/20/2024Jason P RhodesDirectorSell169,539$22.72$3,851,926.08  
2/16/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell162,707$23.14$3,765,039.98  
2/15/2024Jason P RhodesDirectorSell177,906$23.89$4,250,174.34  
2/12/2024Wildon FarwellInsiderSell5,493$25.07$137,709.51  
1/26/2024Richard William ScalzoSVPSell13,000$24.34$316,420.00  
I want to be very real with you (Ad)

Listen, I don’t come at my readers this direct very often, but here goes nothing: There is one strategy that has helped change my life and I’d like to think it has changed the lives of some of my readers, too. We’ve had success stories but I won’t even show you here because I don’t want you to get unrealistic expectations since individual results do vary. But the point is, this thing is the real deal. There’s a reason I consider it my flagship, even with all the market advantages I’ve discovered in recent years.

1/26/2024Wildon FarwellInsiderSell100$25.00$2,500.00  
1/9/2024Dirk KerstenDirectorBuy1,714,285$17.50$29,999,987.50  
1/4/2024Joshua T BrummCEOSell218,536$18.51$4,045,101.36  
1/3/2024Oxana BeskrovnayaInsiderSell45,326$18.98$860,287.48  
1/3/2024Richard William ScalzoSVPSell13,000$18.81$244,530.00  
12/14/2023Richard William ScalzoInsiderSell2,376$12.02$28,559.52  
12/11/2023Richard William ScalzoInsiderSell1,380$10.72$14,793.60  
12/11/2023Susanna Gatti HighCOOSell1,616$10.72$17,323.52  
12/6/2023Richard William ScalzoInsiderSell1,872$12.01$22,482.72  
12/4/2023Richard William ScalzoInsiderSell681$12.01$8,178.81  
11/2/2023Susanna Gatti HighCOOSell9,939$7.40$73,548.60  
(Data available from 1/1/2013 forward)

DYN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Dyne Therapeutics includes Dirk Kersten, Jason P Rhodes, John Cox, Jonathan Mcneill, Joshua T Brumm, Oxana Beskrovnaya, Richard William Scalzo, Susanna Gatti High, Venture Fund Xi L.P. Atlas, and Wildon Farwell. Learn more on insiders at DYN.

20.77% of Dyne Therapeutics stock is owned by insiders. Learn more on DYN's insider holdings.

The following insiders have purchased DYN shares in the last 24 months: Dirk Kersten ($29,999,987.50), Jason P Rhodes ($10,000,016.70), and John Cox ($1,057,280.00).

Insiders have purchased a total of 2,680,866 DYN shares in the last 24 months for a total of $41,057,284.20 bought.

The following insiders have sold DYN shares in the last 24 months: Dirk Kersten ($4,419,318.29), Jason P Rhodes ($21,437,005.50), Jonathan Mcneill ($606,505.50), Joshua T Brumm ($9,525,034.91), Oxana Beskrovnaya ($2,148,695.53), Richard William Scalzo ($1,178,126.29), Susanna Gatti High ($5,823,980.41), Venture Fund Xi L.P. Atlas ($20,162,906.51), and Wildon Farwell ($198,713.88).

Insiders have sold a total of 2,848,037 Dyne Therapeutics shares in the last 24 months for a total of $65,500,286.82 sold.



This page (NASDAQ:DYN) was last updated on 10/17/2024 by MarketBeat.com Staff
From Our Partners